person · Reporting owner

LIVERIS ANDREW N

Disclosed activity across 5 companies

Tapewire entity: 14463
SEC CIK: 0001269971

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CITIGROUP INCC · Entity 2837	Director	January 18, 2011	January 20, 2011
DuPont de Nemours, Inc.DWDP · Entity 3297	Former Executive Chairman	June 11, 2018	June 13, 2018
INTERNATIONAL BUSINESS MACHINES CORPIBM · Entity 2840	Director	September 30, 2026	October 02, 2026
Lucid Group, Inc.LCID · Entity 1530	Director	June 04, 2026	June 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CITIGROUP INC

Report date January 18, 2011 · Filed January 20, 2011

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	106,923.7	Reported balance After 2011-01-18 transaction · row 1 1 source row Row 1 · 2011-01-18 · Grant · Acquired 29,880.4 · Balance 106,923.7 F1: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	3,828.7	Reported balance Holding disclosure · report date 2011-01-18 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 3,828.7 F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors.
Common StockSEC Table I · non-derivative	IndirectBy Children	1,200	Reported balance Holding disclosure · report date 2011-01-18 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,200

Filing footnotes · ownership attribution and instrument terms

F1: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors.

F2: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors.

DuPont de Nemours, Inc.

Report date June 11, 2018 · Filed June 13, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	387,618.089	Ending reported balance After 2018-06-12 transaction · row 4 4 source rows · reconciled sequence Row 1 · 2018-06-11 · Exercise / conversion · Acquired 73,902 · Balance 461,520.089 Row 2 · 2018-06-11 · Sale · Disposed 73,902 · Balance 387,618.089 F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.60. Row 3 · 2018-06-12 · Exercise / conversion · Acquired 26,098 · Balance 413,716.089 Row 4 · 2018-06-12 · Sale · Disposed 26,098 · Balance 387,618.089 F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.65.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13	Direct	366,792	Reported balance After 2018-06-11 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-06-11 · Exercise / conversion · Disposed 73,902 · Balance 366,792 F4: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5: The options vested in three annual installments beginning on February 13, 2010.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13	Direct	340,694	Reported balance After 2018-06-12 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-06-12 · Exercise / conversion · Disposed 26,098 · Balance 340,694 F4: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5: The options vested in three annual installments beginning on February 13, 2010.
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan	1,783.2855	Reported balance Holding disclosure · report date 2018-06-11 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 1,783.2855
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan ESOP	4,071.1138	Reported balance Holding disclosure · report date 2018-06-11 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 4,071.1138
Common StockSEC Table I · non-derivative	IndirectBy Trust	799,273.5	Reported balance Holding disclosure · report date 2018-06-11 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 799,273.5

Filing footnotes · ownership attribution and instrument terms

F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.60.

F3: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.65.

F4: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights.

F5: The options vested in three annual installments beginning on February 13, 2010.

INTERNATIONAL BUSINESS MACHINES CORP

Report date September 30, 2026 · Filed October 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Promised Fee ShareSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	45,262	Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-30 · Grant · Acquired 444 · Balance 45,262 F1: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Filing footnotes · ownership attribution and instrument terms

F1: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.

F2: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.

F3: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Lucid Group, Inc.

Report date June 04, 2026 · Filed June 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	126,364	Ending reported balance After 2026-06-04 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-06-04 · Grant · Acquired 43,870 · Balance 123,765 F1: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date. F2: RSUs are settled in shares of Class A Common Stock on a one-for-one basis. Row 2 · 2026-06-04 · Grant · Acquired 2,599 · Balance 126,364 F3: These RSUs vest in full on the date of the grant in connection with past service. F2: RSUs are settled in shares of Class A Common Stock on a one-for-one basis.
Class A Common StockSEC Table I · non-derivative	IndirectBy Liveris Capital Partners LLC	40,000	Reported balance Holding disclosure · report date 2026-06-04 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 40,000 F4: Interests shown consist of 40,000 shares of Class A Common Stock (the "Liveris Capital Shares") beneficially owned by Liveris Capital Partners LLC ("Liveris Capital"). The reporting person has investment control over Liveris Capital and disclaims beneficial ownership of the Liveris Capital Shares. The Liveris Capital Shares were received as part of a distribution from Churchill Sponsor IV LLC applying equally to all securities of a class in January 2023.

Filing footnotes · ownership attribution and instrument terms

F1: These restricted stock units ("RSUs") will vest in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of stockholders held after the date of grant, in each case, subject to the reporting person's continued service on the board of directors through the applicable vesting date. The RSUs are also subject to a deferral election by the reporting person and shares will not be issued until the designated deferred settlement date.

F2: RSUs are settled in shares of Class A Common Stock on a one-for-one basis.

F3: These RSUs vest in full on the date of the grant in connection with past service.

F4: Interests shown consist of 40,000 shares of Class A Common Stock (the "Liveris Capital Shares") beneficially owned by Liveris Capital Partners LLC ("Liveris Capital"). The reporting person has investment control over Liveris Capital and disclaims beneficial ownership of the Liveris Capital Shares. The Liveris Capital Shares were received as part of a distribution from Churchill Sponsor IV LLC applying equally to all securities of a class in January 2023.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

DOW CHEMICAL CO /DE/

Report date August 31, 2017 · Filed September 05, 2017

Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
CommonSEC Table I · non-derivative	Direct	Reported balance After 2017-08-31 transaction · row 1 1 source row Row 1 · 2017-08-31 · Disposition to issuer · Disposed 215,849.089 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 61,190 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 66,750 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 51,890 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
CommonSEC Table I · non-derivative	IndirectBy 401(k) Plan	Reported balance After 2017-08-31 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2017-08-31 · Disposition to issuer · Disposed 1,686.7065 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
CommonSEC Table I · non-derivative	IndirectBy 401(k) Plan ESOP	Reported balance After 2017-08-31 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-08-31 · Disposition to issuer · Disposed 3,673.8586 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
CommonSEC Table I · non-derivative	IndirectBy Trust	Reported balance After 2017-08-31 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2017-08-31 · Disposition to issuer · Disposed 821,324.5 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.00 · Expires 2022-02-10	Direct	Reported balance After 2017-08-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-08-31 · Disposition to issuer · Disposed 516,000 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10	Direct	Reported balance After 2017-08-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2017-08-31 · Disposition to issuer · Disposed 263,860 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.38 · Expires 2021-02-11	Direct	Reported balance After 2017-08-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-08-31 · Disposition to issuer · Disposed 412,380 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.79 · Expires 2020-02-12	Direct	Reported balance After 2017-08-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-08-31 · Disposition to issuer · Disposed 551,800 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12	Direct	Reported balance After 2017-08-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-08-31 · Disposition to issuer · Disposed 331,510 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.53 · Expires 2019-02-13	Direct	Reported balance After 2017-08-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-08-31 · Disposition to issuer · Disposed 909,100 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13	Direct	Reported balance After 2017-08-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2017-08-31 · Disposition to issuer · Disposed 312,670 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.71 · Expires 2024-02-14	Direct	Reported balance After 2017-08-31 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2017-08-31 · Disposition to issuer · Disposed 315,930 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.62 · Expires 2018-02-15	Direct	Reported balance After 2017-08-31 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2017-08-31 · Disposition to issuer · Disposed 619,370 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15	Direct	Reported balance After 2017-08-31 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2017-08-31 · Disposition to issuer · Disposed 761,660 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.

F2: Includes 61,190 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 66,750 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 51,890 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.

F3: This option was fully vested and exercisable at the time of the Merger.

F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.

F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.

F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.

F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 31, 2012 Filed Apr 2, 2012 16:54 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	300	$208.59 Strike: $0.00	$62,577.00	Disclosure SEC source: 0001181431-12-020974 · rrd340804.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,385 Underlying: Common Stock · 300 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
December 31, 2011 Filed Jan 3, 2012 15:40 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	338	$185.14 Strike: $0.00	$62,577.32	Disclosure SEC source: 0001181431-12-000039 · rrd329358.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,074 Underlying: Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 30, 2011 Filed Oct 3, 2011 17:50 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	355	$176.51 Strike: $0.00	$62,661.05	Disclosure SEC source: 0001181431-11-051024 · rrd323067.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,726 Underlying: Common Stock · 355 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2011 Filed Jul 1, 2011 17:00 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	365	$171.60 Strike: $0.00	$62,632.18	Disclosure SEC source: 0001181431-11-039161 · rrd316862.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,361 Underlying: Common Stock · 365 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
March 31, 2011 Filed Apr 1, 2011 17:50 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	383	$163.57 Strike: $0.00	$62,645.40	Disclosure SEC source: 0001181431-11-021195 · rrd307202.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 Underlying: Common Stock · 383 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
January 18, 2011 Filed Jan 20, 2011 21:41 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	29,880.4	$0.00	$0.00	Disclosure SEC source: 0001181431-11-004475 · rrd298032.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,923.7 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
December 31, 2010 Filed Jan 3, 2011 16:05 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	427	$146.51 Strike: $0.00	$62,559.77	Disclosure SEC source: 0001181431-11-000026 · rrd295930.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,599 Underlying: Common Stock · 427 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
September 30, 2010 Filed Oct 1, 2010 17:26 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	464	$134.90 Strike: $0.00	$62,593.60	Disclosure SEC source: 0001181431-10-048658 · rrd287536.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167 Underlying: Common Stock · 464 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
June 30, 2010 Filed Jul 1, 2010 18:16 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	504	$124.11 Strike: $0.00	$62,551.44	Disclosure SEC source: 0001181431-10-035421 · rrd280465.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common Stock · 504 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
March 31, 2010 Filed Apr 1, 2010 18:00 UTC	INTERNATIONAL BUSINESS MACHINES CORP IBM · Entity 2840	GrantPromised Fee Share · Derivative	195	$128.21 Strike: $0.00	$24,999.98	Disclosure SEC source: 0001181431-10-019312 · rrd271762.xml · derivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195 Underlying: Common Stock · 195 shares Expires not disclosed F1 · derivative.exercise_price: Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. F2 · kind: Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. F3 · derivative.exercise_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. F3 · derivative.expiration_date: Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement. Read SEC document
January 19, 2010 Filed Jan 21, 2010 23:20 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	42,662.1	$0.00	$0.00	Disclosure SEC source: 0001181431-10-004069 · rrd262455.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,043.3 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
April 01, 2009 Filed Apr 2, 2009 20:58 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	245.3	$1.31	$321.10	Disclosure SEC source: 0001181431-09-018660 · rrd238390.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,381.2 F1 · shares: Reinvestment of cash, including dividends and interest, under the Issuer's Compensation Plan for Non-Employee Directors. F3 · balance_after: Reflects 1,548.3 shares of deferred common stock which vested on 1/20/2009 and were transferred to the Reporting Person's account in the Issuer's Compensation Plan for Non-Employee Directors in accordance with the terms of the Plan. Read SEC document
April 01, 2009 Filed Apr 2, 2009 20:58 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	29	$1.31	$37.96	Disclosure SEC source: 0001181431-09-018660 · rrd238390.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,828.7 F1 · shares: Reinvestment of cash, including dividends and interest, under the Issuer's Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 14, 2009 Filed Jan 17, 2009 01:15 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	32,106	$0.00	$0.00	Disclosure SEC source: 0001181431-09-003431 · rrd230163.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,684.2 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 01, 2009 Filed Jan 5, 2009 21:35 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	45.7	$7.72	$352.71	Disclosure SEC source: 0001181431-09-000828 · rrd227446.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote (3) Disclosed balance after: 2,251.2 F2 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F3 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 01, 2009 Filed Jan 5, 2009 21:35 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	31.4	$7.72	$242.35	Disclosure SEC source: 0001181431-09-000828 · rrd227446.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,578.2 F2 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
January 01, 2009 Filed Jan 5, 2009 21:35 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	1,133	$7.72	$8,744.49	Disclosure SEC source: 0001181431-09-000828 · rrd227446.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,546.8 F1 · shares: Shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
October 01, 2008 Filed Oct 3, 2008 20:46 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	37.4	$18.58	$694.89	Disclosure SEC source: 0001181431-08-056096 · rrd219575.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote (3) Disclosed balance after: 2,205.5 F2 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F3 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
October 01, 2008 Filed Oct 3, 2008 20:46 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	25.7	$18.58	$477.51	Disclosure SEC source: 0001181431-08-056096 · rrd219575.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,413.8 F2 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
October 01, 2008 Filed Oct 3, 2008 20:46 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	470	$18.58	$8,732.60	Disclosure SEC source: 0001181431-08-056096 · rrd219575.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,388.1 F1 · shares: Award of shares pursuant to the Issuer's 1999 Stock Incentive Plan. Read SEC document
July 01, 2008 Filed Jul 3, 2008 18:31 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	33.4	$20.47	$683.70	Disclosure SEC source: 0001181431-08-042113 · rrd212587.xml · nonDerivative · entry 4 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote (3) Disclosed balance after: 2,168.1 F2 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F3 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
July 01, 2008 Filed Jul 3, 2008 18:31 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	22.9	$20.47	$468.76	Disclosure SEC source: 0001181431-08-042113 · rrd212587.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,918.1 F2 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
July 01, 2008 Filed Jul 3, 2008 18:31 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	427	$20.47	$8,740.69	Disclosure SEC source: 0001181431-08-042113 · rrd212587.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,895.1 F1 · shares: Award of shares pursuant to the Issuer's 1999 Stock Incentive Plan. Read SEC document
May 19, 2008 Filed Jul 3, 2008 18:31 UTC	CITIGROUP INC C · Entity 2837	GiftCommon Stock	800	$0.00	$0.00	Disclosure SEC source: 0001181431-08-042113 · rrd212587.xml · nonDerivative · entry 5 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By children Disclosed balance after: 1,200 Read SEC document
May 19, 2008 Filed Jul 3, 2008 18:31 UTC	CITIGROUP INC C · Entity 2837	GiftCommon Stock	800	$0.00	$0.00	Disclosure SEC source: 0001181431-08-042113 · rrd212587.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468.1 Read SEC document
May 13, 2008 Filed May 15, 2008 20:01 UTC	CITIGROUP INC C · Entity 2837	PurchaseCommon Stock	400	$23.46	$9,383.60	Disclosure SEC source: 0001181431-08-031705 · rrd206841.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By child Disclosed balance after: 400 Read SEC document
May 13, 2008 Filed May 15, 2008 20:01 UTC	CITIGROUP INC C · Entity 2837	PurchaseCommon Stock	800	$23.48	$18,783.20	Disclosure SEC source: 0001181431-08-031705 · rrd206841.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,268.1 Read SEC document
April 01, 2008 Filed Apr 3, 2008 20:30 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	21.8	$21.27	$463.60	Disclosure SEC source: 0001181431-08-023541 · rrd201525.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468.1 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
April 01, 2008 Filed Apr 3, 2008 20:30 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	31.7	$21.27	$674.13	Disclosure SEC source: 0001181431-08-023541 · rrd201525.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote (2) Disclosed balance after: 2,134.7 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 22, 2008 Filed Jan 25, 2008 01:06 UTC	CITIGROUP INC C · Entity 2837	GrantEmployee Stock Options (Right to Buy) · Derivative	36,809.82	$0.00 Strike: $24.45	$0.00	Disclosure SEC source: 0001181431-08-005331 · rrd191875.xml · derivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,809.82 Underlying: Common Stock · 36,809.82 shares Expires 2014-01-22 Read SEC document
January 01, 2008 Filed Jan 3, 2008 21:42 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	57.5	$32.91	$1,892.56	Disclosure SEC source: 0001181431-08-001012 · rrd186509.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,127 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Reflects 422.3 shares of deferred common stock which vested on 1/01/2008 and were transferred to the Reporting Person's deferred compensation account in the Issuer's Compensation Plan for Non-Employee Directors in accordance with the Reporting Person's prior election. Read SEC document
October 01, 2007 Filed Oct 3, 2007 21:00 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	40.7	$46.05	$1,874.03	Disclosure SEC source: 0001181431-07-060677 · rrd174041.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,491.7 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
July 01, 2007 Filed Jul 3, 2007 18:32 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	34.7	$53.52	$1,857.01	Disclosure SEC source: 0001181431-07-043846 · rrd164475.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,451 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
April 01, 2007 Filed Apr 3, 2007 20:49 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	36.7	$50.01	$1,835.44	Disclosure SEC source: 0001181431-07-023236 · rrd151685.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,416.4 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. Read SEC document
January 16, 2007 Filed Jan 18, 2007 23:13 UTC	CITIGROUP INC C · Entity 2837	GrantEmployee Stock Options (Right to Buy) · Derivative	8,275.1	$0.00 Strike: $54.38	$0.00	Disclosure SEC source: 0001181431-07-004712 · rrd143254.xml · derivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,275.1 Underlying: Common Stock · 8,275.1 shares Expires 2013-01-16 Read SEC document
January 16, 2007 Filed Jan 18, 2007 23:13 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	1,377.2	$0.00	$0.00	Disclosure SEC source: 0001181431-07-004712 · rrd143254.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,379.7 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 01, 2007 Filed Jan 3, 2007 22:47 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	19	$51.38	$976.20	Disclosure SEC source: 0001181431-07-000949 · rrd140978.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,002.5 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
October 01, 2006 Filed Oct 3, 2006 20:16 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	19.7	$49.09	$967.03	Disclosure SEC source: 0001181431-06-056343 · rrd131860.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,983.5 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
July 01, 2006 Filed Jul 5, 2006 20:15 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	19.4	$49.44	$959.06	Disclosure SEC source: 0001181431-06-040310 · rrd121842.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963.9 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
April 01, 2006 Filed Apr 4, 2006 20:41 UTC	CITIGROUP INC C · Entity 2837	OtherCommon Stock	20.3	$46.52	$944.30	Disclosure SEC source: 0001181431-06-022052 · rrd111915.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,944.5 F1 · shares: Reinvestment of cash, including dividends and interest, under the Compensation Plan for Non-Employee Directors. F2 · balance_after: Represents deferred shares of common stock held by the Issuer for the benefit of the Reporting Person pursuant to the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 17, 2006 Filed Jan 19, 2006 20:49 UTC	CITIGROUP INC C · Entity 2837	GrantEmployee Stock Options (Right to Buy) · Derivative	9,198.69	$0.00 Strike: $48.92	$0.00	Disclosure SEC source: 0001181431-06-004274 · rrd103924.xml · derivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,198.69 Underlying: Common Stock · 9,198.69 shares Expires 2012-01-17 Read SEC document
January 17, 2006 Filed Jan 19, 2006 20:49 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	1,537.8	$0.00	$0.00	Disclosure SEC source: 0001181431-06-004274 · rrd103924.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,924.2 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document
January 01, 2006 Filed Jan 4, 2006 21:13 UTC	CITIGROUP INC C · Entity 2837	GrantEmployee Stock Options (Right to Buy) · Derivative	2,318.15	$0.00 Strike: $48.53	$0.00	Disclosure SEC source: 0001181431-06-001033 · rrd101958.xml · derivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,318.15 Underlying: Common Stock · 2,318.15 shares Expires 2012-01-01 Read SEC document
January 01, 2006 Filed Jan 4, 2006 21:13 UTC	CITIGROUP INC C · Entity 2837	GrantCommon Stock	386.4	$48.53	$18,751.99	Disclosure SEC source: 0001181431-06-001033 · rrd101958.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386.4 F1 · shares: Deferred shares awarded under the Issuer's Compensation Plan for Non-Employee Directors. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.